Your browser doesn't support javascript.
loading
Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Lam, Elaine T; Wong, Michael K K; Agarwal, Neeraj; Redman, Bruce G; Logan, Theodore; Gao, Dexiang; Flaig, Thomas W; Lewis, Karl; Poust, Jamie; Monk, Paul; Jarkowski, Anthony; Sendilnathan, Arun; Bolden, Marcus; Kuzel, Timothy M; Olencki, Thomas.
Afiliación
  • Lam ET; Departments of *Medicine, Division of Medical Oncology **Biostatistics ††Pharmacy, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO ‡Department of Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA §Roswell Park Cancer Institute ‡‡Department of Pharmacy, Roswell Park Cancer Institute, Buffalo, NY ∥Department of Medicine, Division of Medical Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT ¶Department of Medicine,
J Immunother ; 37(7): 360-5, 2014 Sep.
Article en En | MEDLINE | ID: mdl-25075565
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Interleucina-2 / Inhibidores de Proteínas Quinasas / Neoplasias Renales / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Revista: J Immunother Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Interleucina-2 / Inhibidores de Proteínas Quinasas / Neoplasias Renales / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Idioma: En Revista: J Immunother Año: 2014 Tipo del documento: Article